Home » Stocks » VBIO

Vitality Biopharma Inc. (VBIO)

Stock Price: $0.1200 USD 0.0000 (0.00%)
Updated November 25, 12:42 PM EST - Market open

Stock Price Chart

Key Info

Market Cap 6.10M
Revenue (ttm) 258,288
Net Income (ttm) -2.76M
Shares Out 50.84M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 25
Last Price $0.1200
Previous Close $0.1200
Change ($) 0.0000
Change (%) 0.00%
Day's Open 0.1200
Day's Range 0.1200 - 0.1200
Day's Volume 31,264
52-Week Range 0.01 - 0.35

More Stats

Market Cap 6.10M
Enterprise Value 5.16M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 50.84M
Float 34.10M
EPS (basic) -0.04
EPS (diluted) -0.05
FCF / Share -0.05
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 3.87
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 23.62
PB Ratio 9.53
Revenue 258,288
Operating Income -2.70M
Net Income -2.76M
Free Cash Flow -2.70M
Net Cash 938,708
Net Cash / Share 0.02
Gross Margin -76.07%
Operating Margin -1,043.97%
Profit Margin n/a
FCF Margin -1,045.74%
ROA -59.59%
ROE -188.36%
ROIC 411.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

Current: $0.1200
Target: 10.40
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth---37.31%-34.22%1.09%----
Gross Profit--
Operating Income-3.69-4.57-4.40-3.47-2.74-3.81-3.60-2.55-1.30
Net Income-4.37-13.12-4.31-5.22-0.14-4.05-4.15-2.74-1.32
Shares Outstanding51.5433.0023.1213.597.547.046.015.345.15
Earnings Per Share-0.08-0.61-0.19-0.38-0.02-0.60-0.70-0.50-0.30
Operating Cash Flow-3.59-3.67-2.89-1.38-1.69-2.50-2.13-1.65-0.24
Free Cash Flow-3.59-3.67-2.89-1.38-1.69-2.50-2.13-1.65-0.24
Cash & Equivalents2.436.010.661.150.100.391.400.390.53
Total Debt0.420.30-----0.580.47
Net Cash / Debt2.015.710.661.150.100.391.40-0.190.06
Book Value1.285.020.320.37-0.52-1.08-0.11-0.57-0.05
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Vitality Biopharma Inc.
Country United States
Employees 3
CEO Michael Cavanaugh

Stock Information

Ticker Symbol VBIO
Stock Exchange US OTC
Sector Healthcare
Industry Biotechnology
Unique Identifier OTCMKTS: VBIO


Vitality Biopharma engages in the development of cannabinoid pharmaceuticals for the treatment of inflammatory disorders in the United States. The company is developing tetrahydrocannabinol glycoside (VBX-100), an oral cannabinoid prodrug for inflammatory bowel disease and irritable bowel syndromes. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. Vitality Biopharma, Inc. was founded in 2007 and is headquartered in Los Angeles, California.